EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice

Sabrine Bilel, Erica Zamberletti, Lucia Caffino iD, Micaela Tirri, Francesca Mottarlini iD, Raffaella Arfè, Mario Barbieri, Sarah Beggiato, Federica Boccuto, Tatiana Bernardi, Sara Casati iD, Anna T Brini and 5 more

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16164 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Sabrine Bilel and 16 co-authors. Institution: Department of Translational Medicine, Section of Legal Medicine and LTTA Center, University of Ferrara, Ferrara, Italy. Major MEDLINE topics: Cannabinoids, Cognitive Dysfunction. Cited 18 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY 4.0). Funded by: Università degli Studi di Ferrara.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Psychotic disorders have been reported in long‐term users of synthetic cannabinoids. This study aims at investigating the long‐lasting effects of repeated JWH‐018 exposure. Experimental Approach Male CD‐1 mice were injected with vehicle, JWH‐018 (6 mg·kg −1 ), the CB 1 ‐antagonist NESS‐0327 (1 mg·kg −1 ) or co‐administration of NESS‐0327 and JWH‐018, every day for 7 days. After 15 or 16 days washout, we investigated the effects of JWH‐018 on motor function, memory, social dominance and prepulse inhibition (PPI). We also evaluated glutamate levels in dialysates from dorsal striatum, striatal dopamine content and striatal/hippocampal neuroplasticity focusing on the NMDA receptor complex and the neurotrophin BDNF. These measurements were accompanied by in vitro electrophysiological evaluations in hippocampal preparations. Finally, we investigated the density of CB 1 receptors and levels of the endocannabinoid anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) and their main synthetic and degrading enzymes in the striatum and hippocampus. Key Results The repeated treatment with JWH‐018 induced psychomotor agitation while reducing social dominance, recognition memory and PPI in mice. JWH‐018 disrupted hippocampal LTP and decreased BDNF expression, reduced the synaptic levels of NMDA receptor subunits and decreased the expression of PSD95. Repeated exposure to JWH‐018, reduced hippocampal CB 1 receptor density and induced a long‐term alteration in AEA and 2‐AG levels and their degrading enzymes, FAAH and MAGL, in the striatum. Conclusion and Implications Our findings suggest that repeated administration of a high dose of JWH‐018 leads to the manifestation of psychotic‐like symptoms accompanied by alterations in neuroplasticity and change in the endocannabinoid system.

Subjects

MeSH terms (MEDLINE)

CannabinoidsCognitive DysfunctionMiceMaleAnimalsEndocannabinoidsBrain-Derived Neurotrophic FactorReceptors, N-Methyl-D-AspartateNeuronal PlasticityReceptor, Cannabinoid, CB1IndolesNaphthalenes

Author keywords

BDNFGABA/glutamate releaseJWH-018LTPhippocampusnovel object recognitionstriatumsynthetic cannabinoid

Substances

EndocannabinoidsBrain-Derived Neurotrophic FactorReceptors, N-Methyl-D-AspartateCannabinoidsReceptor, Cannabinoid, CB11-pentyl-3-(1-naphthoyl)indoleIndolesNaphthalenes

Authors and institutions

  • Department of Translational Medicine, Section of Legal Medicine and LTTA Center, University of Ferrara, Ferrara, Italy.
  • Department of Biotechnology and Life Sciences (DBSV) and Neuroscience Center, University of Insubria, Busto Arsizio, Italy.
  • Department of Pharmacological and Biomolecular Sciences, 'Rodolfo Paoletti', Università degli Studi di Milano, Milan, Italy.
  • Department of Neurosciences and Rehabilitation, University of Ferrara, Ferrara, Italy.
  • Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy.
  • Department of Environmental Sciences and Prevention, University of Ferrara, Ferrara, Italy.

ORCID profiles: Lucia Caffino, Francesca Mottarlini, Sara Casati, Fabio Fumagalli, Matteo Marti

Funding

  • Università degli Studi di Ferrara

Cite

APA

Bilel, S., Zamberletti, E., Caffino, L., Tirri, M., Mottarlini, F., Arfè, R., Barbieri, M., Beggiato, S., Boccuto, F., Bernardi, T., Casati, S., Brini, A. T., Parolaro, D., Rubino, T., Ferraro, L., Fumagalli, F., & Marti, M. (2023). Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.16164

Vancouver

Bilel S, Zamberletti E, Caffino L, Tirri M, Mottarlini F, Arfè R, et al. Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice. British Journal of Pharmacology. 2023. doi:10.1111/bph.16164

BibTeX
@article{Bilel2023,
  author = {Bilel, Sabrine and Zamberletti, Erica and Caffino, Lucia and Tirri, Micaela and Mottarlini, Francesca and Arfè, Raffaella and Barbieri, Mario and Beggiato, Sarah and Boccuto, Federica and Bernardi, Tatiana and Casati, Sara and Brini, Anna T and Parolaro, Daniela and Rubino, Tiziana and Ferraro, Luca and Fumagalli, Fabio and Marti, Matteo},
  title = {Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16164}
}
Start for free →